From January 1, 2022 to March 31, 2022, the company has repurchased 587,900 shares, representing 0.98% for CNY 20.26 million. With this, the company has completed the repurchase of 587,900 shares, representing 0.98% for CNY 20.26 million under the buyback announced on November 26, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.73 CNY | +1.94% |
|
+0.06% | -35.32% |
1st Jan change | Capi. | |
---|---|---|
-35.32% | 174M | |
+3.60% | 102B | |
-10.18% | 59.99B | |
+82.86% | 51.32B | |
+4.83% | 34.84B | |
-0.39% | 30.66B | |
+5.85% | 18.79B | |
+20.79% | 17.98B | |
+7.97% | 13.79B | |
+78.32% | 13.28B |
- Stock Market
- Equities
- 003017 Stock
- News Zhe Jiang Dayang Biotech Group Co., Ltd.
- Tranche Update on Zhejiang Dayang Biology Technology Co.,Ltd.'s Equity Buyback Plan announced on November 26, 2021.